Corporate Information

Company Name Eisai Co., Ltd.
Date Established December 6, 1941
Head Office 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan
Telephone 81-3-3817-3700
Representatives Haruo Naito, Representative Corporate Officer and CEO
Hideki Hayashi, Representative Corporate Officer, Japan Business and CIO
Yasushi Okada, Representative Corporate Officer, CTO, Industry Affairs and China Business
Capital 44,986 million Yen (as of March 31, 2018)
Scope of Business Research and development, manufacture, sale and import and export of pharmaceuticals
Employees Consolidated : 10,456
Non-Consolidated : 3,172 (as of March 31, 2018)
Production Plants Kawashima Plant (Gifu Prefecture)
Kashima Business Office (Ibaraki Prefecture)
Eisai Manufacturing Ltd. (U.K.)
Eisai China Inc. Suzhou Plant (China)
Eisai (Liaoning) Pharmaceutical Co., Ltd. Benxi Plant (China)
Eisai Pharmaceuticals India Pvt. Ltd. (India), etc.
Laboratories Tsukuba Research Laboratories (Ibaraki Prefecture)
Kawashima Plant (Gifu Prefecture)
Kashima Business Office (Ibaraki Prefecture)
KAN Research Institute, Inc. (Hyogo Prefecture)
Andover Research Institute (U.S.A.)
Exton Site (U.S.A.)
H3 Biomedicine Inc. (U.S.A.)
Hatfield Research Institute (U.K.), etc.
Overseas Sales Offices Eisai Inc. (U.S.A.)
Eisai Ltd. (U.K.)
Eisai GmbH (Germany)
Eisai S.A.S. (France)
Eisai China Inc. (China)
Eisai Korea Inc. (South Korea), etc.

Stock Information

Fiscal Year End March 31
Record Date for Dividend Year-end dividend - March 31
Interim dividend - September 30
Annual Shareholders' Meeting June
Stock Exchange Listings Tokyo Stock Exchange
Stock Trading Unit 100 shares
Ticker Code 4523
เว็บพนันบอล ดีที่สุด pantip sitemap bet365 combet royal online mobile gclubroyal1688 bet365mobile Mobile W88 gclub royal1688 scr888online||||||||||||||||||||||||||||||||||||||||||